See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: Sept. 10, 2004

Lung Cancer Ovarian Cancer Eczema (Atopic Dermatitis - Pediatric)

(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:

Lung Cancer

A research study to measure the effects of an investigational medication on progression of lung cancer. Volunteers over age 18 who have a confirmed diagnosis of non-small cell lung cancer and who have not previously received chemotherapy as the primary treatment for lung cancer may be eligible. Research sites located throughout the United States.

More Information

Please see http://www.centerwatch.com/patient/studies/cat34.html.

-----

Ovarian Cancer

A research study of an investigational medication for the treatment of ovarian cancer. Women 18 or older who have a diagnosis of epithelial cancer of the ovary, fallopian tube or primary peritoneal cancer and who have had progression after platinum-based chemotherapy or after therapy with Doxil/Caelyx or Hycamtin may be eligible. Research sites located throughout the United States.

More Information

Please see http://www.centerwatch.com/patient/studies/cat186.html.

-----

Eczema (Atopic Dermatitis - Pediatric)

A research study of an investigational medication for children with eczema. Children between 3-18 months of age who have had eczema for less then three months, and who have a parent or sibling with a history of eczema, allergies, or asthma may be eligible. Research site located in Walnut Creek, Calif.

More Information

Please see http://www.centerwatch.com/patient/studies/cat625.html.

-----

Copyright 2004 CenterWatch. All rights reserved.

Consumer News

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.